P&T Community

Visit BIOTECHNOLOGY HEALTHCARE and review the newly designed magazine.

View the new Formulary Kits for Aromasin, Bystolic, Fosrenol, Gelclair, Lialda, and Vyvanse.



David Nash, M.D, M.B.A., Editor in Chief
David Nash is The Dr. Raymond C. and Doris N. Grandon Professor and Chairman of the Department of Health Policy at Jefferson Medical College of Thomas Jefferson University in Philadelphia. From 1996 to 2003, he served as the first Associate Dean for Health Policy at Jefferson Medical College. In 2004, he was named Co-director of the Masters Program in Public Health at Jefferson. Call For Papers P&T Journal is now accepting article submissions from its readers. We welcome a wide variety of manuscripts, including drug class reviews, disease state management reviews, pharmacoeconomic analyses, outcomes research evaluations, DUEs, P&T committee experiences, commentaries, book reviews, and letters to the editor. Please see our author guidelines below or contact the editor, Sonja Sherritze, via phone 267-685-2779 or email: ssherritze@medimedia.com. Guidelines For Authors June 2008 Table of Contents Highlights COVER STORY: Challenges in Evaluating and Standardizing Medical Devices in Health Care Facilities MEDICATION ERRORS The High Cost of Medications

P&T Community

Update Your Registration Profile

Haven't received your weekly newsletters about the new features on PTcommunity.com? Check your newsletter status by clicking here. Scroll down to the question, 'Check here if you would like to receive our e-newsletter?' and choose 'Yes' or 'No.'

Having trouble with the site? Send an email.

PTcommunity.com is assembling an advisory board of formulary experts to provide editorial direction and content to the Web site. Experts from hospitals, managed care organizations, pharmaceutical industry, and the academic and private sectors will serve on the Advisory Board, playing integral roles in the evolution of PTcommunity.com. Contact Tony Berberabe, Senior Web Editor, for more information.

Drug Database: The Triple i Prescribing Guide

Pharmacy Policies/Procedures: Forms and guidelines

Cost Calculators: Exclusive online tools to evaluate your pharmacy costs

Links: A comprehensive map of web links to the world of managed care pharmacy

News by category
• FDA Updates
• Drug Trials and Comparisons
• Managed Pharmacy Trends
• Legislation and Policy
• Foreign Drug Development

Requires
Flash Player 9
Version Test
Download Flash

Digital edition

Web-based
Free to all
All the words and pictures of the print edition
Searchable
Can be downloaded to read offline

Archive digital issues of P&T Journal:

Print Edition

Free to qualified professionals in the U.S.
Others may subscribe for $85/year U.S.; $120/year outside U.S.

Supplements focus on specific formulary issues that affect P&T decision makers. They often provide continuing education credit for physicians, pharmacists, and other health care providers.
	Pharmacological Considerations In Acute Coronary Syndrome (ACS): An Expert Debate
Also available: Self-Monitoring of Blood Glucose (SMBG): Considerations for Intensive Diabetes Management Raising Expectations in the Management of Overactive Bladder with Urge Urinary Incontinence: Clinical and Economic Implications for Health Care Providers Professional Collaboration Day: Synergy Through Collaboration Panel Considerations in Creating a Medicare Part D Formulary

Introducing the Product Profiler, providing detailed information about a specific therapeutic agent to help manage formularies and establish medication-related policies.
	Product Profiler: Revlimid
	Product Profiler: Remicade

Coming Soon: Vaprisol

Visit Formkit.com to view the newest formulary kits, now available online:

Abraxane (paclitaxel protein-bound particles for injectable suspension)

Arimidex (anastrozole)

Aromasin (exemestane tablets) NEW FORMULARY KIT

Bystolic (nebivolol) UPDATED FORMULARY KIT

Boniva (ibandronate sodium)

Campral (acamprosate calcium)

Eraxis (anidulafungin IV)

Faslodex (fulvestrant injection)

Fosrenol (lanthanum carbonate)

Gelclair (biadherent oral gel)

Lexapro (escitalopram oxalate)

Lialda (mesalamine)

Namenda (memantine HCl)

Nexium (esomeprazole magnesium)

Revlimid (lenalidomide)

Tev-Tropin (somatropin, rDNA origin, for injection)

Veramyst (fluticasone furoate)

Vyvanse (lisdexamfetamine dimesylate)

PTCommunity.com provides its subscribers access to the P&T Digest series — peer-reviewed publications that provides pharmacists, physicians, and other health care providers who serve on pharmacy and therapeutics committees up-to-date information about the most efficacious and cost-effective medical treatments for a variety of illnesses.